Navigation Links
California Healthcare Institute Appoints Vice President-State Government Affairs
Date:3/12/2013

LA JOLLA, Calif. (PRWEB) March 11, 2013

The California Healthcare Institute (CHI) announced today the appointment of Eve Bukowski as vice president of state government affairs based in CHI’s Sacramento Office. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

As CHI’s vice president of state government affairs, Bukowski is responsible for managing CHI's Sacramento office, where she directs the organization's state government relations advocacy and outreach activities across a range of issues, including implementation of the Affordable Care Act, tax issues, education and workforce development and environmental regulation.

“As our economy continues to recover, it is crucial that California’s biomedical community has strong representation in Sacramento,” said CHI President and CEO David L. Gollaher, Ph.D. “Eve brings a wealth of experience in government affairs and legislative advocacy, enabling CHI to build and maintain strong ties with legislators and the governor, while fostering exceptional member relations. I am delighted to welcome her to CHI.”

Bukowski most recently served as executive director for TechNet, a trade association representing biotechnology, clean technology, high-tech, venture capital firms and social media companies. During her tenure, she was responsible for developing and implementing TechNet’s legislative agenda and strategy. In this capacity, Eve developed strong relationships with leading policymakers, advocating and advancing key issues of importance to the industry before the state Legislature, administration and agencies on behalf of TechNet. Prior to her work there, Bukowski served as the government affairs manager at the Port of Oakland, where she directed all Port interaction with federal, state and local government officials. Bukowski is a member of the California State Bar, and holds a law degree from the UC Davis School of Law and bachelor’s degree in government from Pomona College.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter, Facebook, LinkedIn and YouTube.

Editorial note: Photo available upon request.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10514355.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
4. Agendia Signs Contract with Blue Shield of California
5. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
6. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
7. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
8. Lightning Brewery’s Craft Beer Old Tempestuous Ale Wins Best of Show at 2012 California State Fair Commercial Brewing Competition
9. Californians Take One Step Closer to Directly Accessing Physical Therapy Services for Immediate Treatment
10. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
11. California Physical Therapists Prediction Proved "Right" by Results of State Board Audit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... KY and San Diego, CA (PRWEB) , ... April 29, 2016 ... ... National Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell ... Dr. Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research ...
(Date:4/29/2016)... TURIN, Italy , April 29, 2016 ... version 5.11, the latest update to its industry-leading treatment ... has shown that Monaco version ... Users can now attain calculation speeds up to four ... Monaco . With the industry,s gold standard ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... biotechnology acceleration company reports the Company,s CEO  was ... capital titled Accelerators Enter When VCs Fear To ... Life Science Leader magazine is an ... work for everything from emerging biotechs to Big ...
(Date:4/28/2016)... ... April 28, 2016 , ... Next week on ... on its first-in-class technologies for tissue stem cell counting and expansion to gene-editing ... to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. , The attention of ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
Breaking Biology News(10 mins):